Psoriasis Clinical Trial

Adherence to Otezla

Summary

Most people with psoriasis have very limited disease, yet that disease may still have a large impact on their lives. While limited psoriasis may be amenable to topical treatment, patients are exceptionally poorly adherent to topical treatment, especially over the long run.

View Full Description

Full Description

Psoriasis patients prefer oral treatments and are more adherent to orals than to topicals, but adherence to oral treatment of psoriasis may still be limited, compromising treatment outcomes. How well the medication works in the patients who take treatment regularly is not well characterized.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult 18 years or older
Diagnosis of mild psoriasis with Otezla recommendation
Non-pregnant
English speaking

Exclusion Criteria:

Under 18 years of age
Not diagnosis of mild psoriasis
Pregnant
Non-English speaking

Study is for people with:

Psoriasis

Phase:

Early Phase 1

Estimated Enrollment:

84

Study ID:

NCT05601492

Recruitment Status:

Not yet recruiting

Sponsor:

Wake Forest University Health Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Wake Forest University Health Sciences
Winston-Salem North Carolina, 27157, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Early Phase 1

Estimated Enrollment:

84

Study ID:

NCT05601492

Recruitment Status:

Not yet recruiting

Sponsor:


Wake Forest University Health Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.